ABBOTT LABORATORIES acquired Cardiovascular Systems, Inc. (CSI) for $851 million ($20.00 per common share), a transaction completed in April 2023, structured as All-cash.
Cardiovascular Systems, Inc. (CSI) operates in Medical devices — vascular, is based in St. Paul, Minnesota, USA. Cardiovascular Systems, Inc. (CSI) makes an atherectomy system used in treating peripheral and coronary artery disease, adding complementary technologies to Abbott's portfolio of vascular device offerings.
CSI's atherectomy system adds complementary technologies to Abbott's portfolio of vascular device offerings.
Complementary atherectomy technology for Abbott Vascular. Integrated into Abbott's Medical Devices (Vascular) business
On April 27, 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI). CSI's atherectomy system, which is used in treating peripheral and coronary artery disease, adds complementary technologies to Abbott's portfolio of vascular device offerings.Abbott FY2023 10-K, Item 1 Business
Advisory firms were not disclosed for this transaction.